Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-20 7:09 pm Purchase |
2022-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Opaleye Management Inc. | 1,560,000 3.610% |
616,298 (+65.31%) |
Filing History |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Larimar Therapeutics, Inc. LRMR |
RA Capital Management, L.P. | 0 0.000% |
-1,334,610 (Position Closed) |
Filing History |
| 2022-09-16 5:19 pm Purchase |
2022-09-16 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 16,963,029 42.450% |
11,126,786 (+190.65%) |
Filing History |
| 2022-02-18 4:32 pm Purchase |
2022-02-15 | 13G | Larimar Therapeutics, Inc. LRMR |
Opaleye Management Inc. | 943,702 5.320% |
943,702 (New Position) |
Filing History |
| 2022-02-15 2:43 pm Sale |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
ACUTA CAPITAL PARTNERS LLC | 0 0.000% |
-863,100 (Position Closed) |
Filing History |
| 2022-02-14 4:11 pm Sale |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
RA Capital Management, L.P. | 1,334,610 7.500% |
-180,541 (-11.92%) |
Filing History |
| 2022-02-11 5:27 pm Sale |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Vivo Capital IX, LLC | 326,888 1.800% |
-326,891 (-50.00%) |
Filing History |
| 2022-02-11 4:29 pm Sale |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
ORBIMED ADVISORS LLC | 0 0.000% |
-732,323 (Position Closed) |
Filing History |
| 2022-02-11 11:34 am Unchanged |
2021-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
CHI Advisors LLC | 1,515,148 8.560% |
0 (Unchanged) |
Filing History |
| 2021-07-02 5:08 pm Purchase |
2021-06-30 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 5,836,243 32.940% |
686,171 (+13.32%) |
Filing History |
| 2021-05-26 1:48 pm Unchanged |
2021-05-25 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 5,150,072 33.500% |
0 (Unchanged) |
Filing History |
| 2021-05-21 5:05 pm Purchase |
2021-05-21 | 13D | Larimar Therapeutics, Inc. LRMR |
Flynn James E | 5,150,072 33.500% |
5,533 (+0.11%) |
Filing History |
| 2021-03-02 1:58 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
CHI Advisors LLC | 1,515,148 9.900% |
1,515,148 (New Position) |
Filing History |
| 2021-02-16 4:47 pm Purchase |
2021-02-04 | 13G | Larimar Therapeutics, Inc. LRMR |
Logos Global Master Fund LP | 300,000 2.000% |
300,000 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
RA Capital Management, L.P. | 1,515,151 9.900% |
1,515,151 (New Position) |
Filing History |
| 2021-02-16 3:11 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
683 Capital Management, LLC | 220,136 1.400% |
220,136 (New Position) |
Filing History |
| 2021-02-16 1:03 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Sio Capital Management, LLC | 188,661 1.230% |
188,661 (New Position) |
Filing History |
| 2021-02-16 08:57 am Unchanged |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
Sphera Funds Management Ltd. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-02-16 06:11 am Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
ACUTA CAPITAL PARTNERS LLC | 863,100 5.600% |
863,100 (New Position) |
Filing History |
| 2021-02-12 4:57 pm Purchase |
2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR |
ORBIMED ADVISORS LLC | 732,323 4.770% |
732,323 (New Position) |
Filing History |